Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) ABR Of 1
May 1, 2016 10:32 am·

Excerpts:
"Analysts have a buy call on Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) stock. As of 2016-04-30, it had an ABR of 1. The rating is fixed on a scale of 1-5. Here three stands for hold call. This analyst brokerage rating computation is based on 1 calls.

The one-year target of Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) stock is $4 and the median target is $4. The range varies in between $4 and $4, indicating a standard deviation of 0%.

Zacks conducts its research on the broad scale and assigns ABR to stocks on behalf of several investment sites. The rating can be stated as the mean of research calls of different brokerages on a stock. ABR can come in decimals while Rank assigned by Zacks comes only in whole numbers."

Article at:
http://theenterpriseleader.com/analyst-research/rock-creek-pharmaceuticals-inc-nasdaqrcpi-abr-of-1/97028/